Proximo Medical Named the Commercialization Partner for BIOTRONIK, Inc.’s Peripheral Vascular Intervention Portfolio in Select U.S. Markets

CASTLE PINES, COLO.  Proximo Medical, LLC today announced that it is the commercial partner for BIOTRONIK, Inc.’s peripheral vascular intervention (PVI) platform in select United States markets. BIOTRONIK, a global medical technology company headquartered in Berlin, Germany with U.S. offices in New York City and Lake Oswego, Oregon, develops trusted and innovative cardiovascular and endovascular solutions. Read more

Proximo Medical Expands Portfolio with PMT Partners

Business acceleration solution to commercialize syringe technology for angiography

Proximo Medical today announced it has been selected by PMT Partners, a medical device innovator focused on the advancement of angiographic injectors, for commercialization of the PowrSyringe and AirTight Control Syringe technologies. Read more

Proximo Medical Selected as Commercialization Partner for Walk Vascular

Novel approach to start-up medical device commercialization capturing attention of innovators, investors.

Proximo Medical today announced that it has been selected as the marketing and commercial partner for Walk Vascular, an innovative medical device company that has developed JETi, a novel Peripheral Thrombectomy Catheter. Read more

Proximo Medical Announces New Client Win With EMBA

Extends Proximo Medical’s leadership in marketing and commercialization solutions for medical device innovators

Proximo Medical today announced that it has been selected as the marketing and commercialization partner of choice for EMBA Medical Limited, a medical device company that designs and develops peripheral embolization technologies focused on improving safety, control, and outcomes. Read more